Heiwa Kanamori
Overview
Explore the profile of Heiwa Kanamori including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
205
Citations
1547
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tachibana T, Miyazaki T, Matsumura A, Hagihara M, Tanaka M, Koyama S, et al.
Cytotherapy
. 2024 Apr;
26(8):921-929.
PMID: 38625069
Background: Various biomarkers have been developed and evaluated to predict the prognosis and complications of allogeneic hematopoietic cell transplantation (HCT). Most previous studies conducted on different biomarkers evaluated single effects...
2.
Miyazaki T, Tachibana T, Suzuki T, Izumi A, Fujimaki K, Sato S, et al.
Transplant Cell Ther
. 2024 Jan;
30(4):400.e1-400.e9.
PMID: 38253183
There are no clear criteria for selecting elderly patients with hematologic malignancies eligible for allogeneic hematopoietic stem cell transplantation (HSCT). This study aimed to evaluate inflammatory and nutritional status biomarkers...
3.
Nukui J, Tachibana T, Miyazaki T, Tanaka M, Matsumoto K, Ishii Y, et al.
Int J Hematol
. 2023 Dec;
119(1):62-70.
PMID: 38082200
The clinical implications of recipient bone marrow nucleated cell count (NCC) prior to allogeneic hematopoietic stem cell transplantation (allo-HSCT) remain unknown. We conducted a multicenter retrospective study to evaluate the...
4.
Sakuma T, Fujisawa S, Tanaka M, Hagihara M, Fujita H, Fujimaki K, et al.
Hematol Oncol
. 2023 Sep;
42(1):e3228.
PMID: 37731313
The CFA ratio, calculated using pretreatment C-reactive protein (CRP), fibrinogen, and albumin levels (CRP × fibrinogen/albumin), was previously reported to be a significant prognostic factor for acute myeloid leukemia (AML)....
5.
Kako S, Kimura S, Wada H, Komiya Y, Nakasone H, Sakurai M, et al.
Leuk Res
. 2023 Aug;
133:107371.
PMID: 37595372
The optimal bridge strategy at the decision for allogeneic hematopoietic stem cell transplantation (HSCT) in patients with myelodysplastic syndrome (MDS) is unclear. We performed a prospective observational study in which...
6.
Hirose N, Tachibana T, Izumi A, Sato S, Tadera N, Tamai Y, et al.
Hematology
. 2023 Jun;
28(1):2220518.
PMID: 37272552
Objectives And Methods: This single-center retrospective study was performed to evaluate the safety and efficacy of FMS-like tyrosine kinase 3 (FLT3) inhibitors before and after allogeneic hematopoietic cell transplantation (HCT)...
7.
Harada K, Onizuka M, Mori T, Shimizu H, Seo S, Aotsuka N, et al.
Int J Infect Dis
. 2023 Mar;
131:79-86.
PMID: 37001798
Objectives: Influenza virus infection (IVI) occasionally causes lower respiratory tract infection (LRTI) in allogeneic hematopoietic stem cell transplantation (allo-HSCT) recipients. Although the progression to LRTI entails a high mortality, the...
8.
Fujimaki K, Hibino Y, Kishimoto K, Watanabe S, Koyama S, Ando T, et al.
Blood Cell Ther
. 2023 Jan;
4(2):44-47.
PMID: 36712898
The prognosis for relapsed adult T-cell leukemia/lymphoma (ATL) after allogeneic hematopoietic stem cell transplantation is poor. Here, we report the case of a 67-year-old man who survived for 26 months...
9.
Najima Y, Tachibana T, Takeda Y, Koda Y, Aoyama Y, Toya T, et al.
Ann Hematol
. 2022 Sep;
101(12):2719-2729.
PMID: 36149461
This 3+3 dose-escalation phase I multicenter study investigated the optimal dose of azacitidine (AZA) for post-hematopoietic stem cell transplantation (HSCT) maintenance, which remains unknown in Japan. Recipients of a first...
10.
Teshigawara-Tanabe H, Hagihara M, Aoki J, Koyama S, Takahashi H, Nakajima Y, et al.
Hematology
. 2022 May;
27(1):620-628.
PMID: 35621915
: Allogeneic hematopoietic stem cell transplantation (allo-HCT) is the only curative treatment for myelodysplastic syndromes (MDS), although predicting post-transplant outcomes remains inconclusive. This study evaluated patients who underwent allo-HCT for...